CI Investments Inc
MRTX

CI Investments Inc’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

CI Investments Inc’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed – – 1355
2022
Q4 		$0 Hold
3
– – ﹤0.01% 1412
2022
Q3 		$0 Hold
3
– – ﹤0.01% 1401
2022
Q2 		$0 Sell
3
-246
-99% -$15.6K ﹤0.01% 1454
2022
Q1 		$20K Buy
249
+4
+2% +$409 ﹤0.01% 1052
2021
Q4 		$36K Buy
245
+47
+24% +$7.3K ﹤0.01% 1048
2021
Q3 		$35K Buy
+198
New +$31.9K ﹤0.01% 1013
2021
Q1 		– Sell
-2,359
Closed -$518K – 1065
2020
Q4 		$518K Buy
2,359
+126
+6% +$27.2K ﹤0.01% 499
2020
Q3 		$371K Buy
+2,233
New +$306K ﹤0.01% 463

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CI Investments Inc's MRTX Position: Q1 2023 in Review

CI Investments Inc sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2023, closing a stake of 3 shares.

CI Investments Inc first reported a position in MRTX in Q3 2020 and held it in 8 quarters. The position peaked at $518K in Q4 2020. 221 funds tracked by Wall St. Rank hold MRTX as of Q1 2023.

  • CI Investments Inc reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • CI Investments Inc sold 3 Mirati Therapeutics, Inc. Common Stock shares in Q1 2023.
  • CI Investments Inc first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • CI Investments Inc's Mirati Therapeutics, Inc. Common Stock position peaked at $518K in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2023.

Based on CI Investments Inc's 13F filing for Q1 2023, filed 12 May 2023.